Target intelligence / Profile preview

Prenylated Rab acceptor protein 1 (RABAC1)

Target
RABAC1
Molecular classification
Other (Rab effector protein), Integral membrane protein
01

Overview

Prenylated Rab acceptor protein 1 (RABAC1, also known as PRA1) is a highly conserved, multi-pass integral membrane protein primarily localized to the Golgi apparatus and also found at endoplasmic reticulum (ER)–mitochondria membrane contact sites. RABAC1 binds prenylated Rab GTPases and helps direct their proper targeting to distinct membrane compartments, thereby regulating vesicular trafficking and protein transport[1][2]. It interacts with various proteins involved in cell signaling and trafficking, including α-synuclein and viral proteins, indicating its functional relevance to intracellular signaling, lipid metabolism, and potential disease processes. RABAC1 exhibits tumor-suppressive activity in certain contexts by promoting apoptosis and inhibiting cancer cell migration and proliferation. It is downregulated in models of retinal degeneration, highlighting a possible role in neurodegeneration. Despite early hypotheses of its function as a general Rab GTPase regulator, recent studies suggest it may also have specialized roles in lipid handling and maintenance of early secretory pathway integrity[1][2].

Other names
PRA1PRAF1YIP3PRA1 family protein 1PRA1 domain family 1Rab acceptor 1 (prenylated)prenylated Rab acceptor 1prenylated Rab acceptor protein 1RABAC1
02

Biological functions

Vesicular traffickingProtein transportIntracellular signalingLipid trafficking/metabolismCell signaling regulationProtein–protein interaction modulationTumor suppressor activity
03

Disease associations

Cancer (tumor suppressive effects, impact on cell proliferation and migration)Retinal degenerative disease (involved in retinitis pigmentosa in animal models)Neurodegenerative disease (interacts with α-synuclein, relevant to diseases like Parkinson's)

Beyond the preview

Go deeper on Prenylated Rab acceptor protein 1 (RABAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prenylated Rab acceptor protein 1 (RABAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call